This is a demo store. No orders will be fulfilled.

CD86 Mouse mAb

    应用:
  • Flow Cytometry
  • 宿主种属: 小鼠(Mouse)
  • 种属反应性: 人(Human)
  • 亚型: Mouse IgG1
  • 克隆号: BU63
  • 偶联: Unconjugated
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
Ab095464-10μg
10μg 现货 Stock Image
Ab095464-50μg
50μg 现货 Stock Image
Ab095464-100μg
100μg 现货 Stock Image
Ab095464-1mg
1mg 期货 Stock Image

基本信息

产品名称 CD86 Mouse mAb
别名 CD86小鼠单克隆抗体 | CD86小鼠单抗
英文别名 Activation B7-2 antigen | B70 | BU63 | CTLA-4 counter-receptor B7.2 | FUN-1
规格或纯度 无载体, ExactAb™, 无叠氮钠, 已验证, 见COA
宿主种属 小鼠(Mouse)
特异性 CD86
种属反应性 人(Human)
免疫原 ARH 77 (B lymphoblastoid cell line).
阳性对照 Flow: Human peripheral blood monocyte.
偶联 Unconjugated

产品属性

克隆类型 单克隆抗体
克隆号 BU63
Format Whole IgG
亚型 Mouse IgG1
SDS-PAGE 150 kDa
纯化方法 Protein G purified
物理外观 Liquid
储存缓冲液 10mM PBS, 0.1% Proclin 300, pH 7.2-7.4
防腐剂 0.1% Proclin 300
浓度 见COA
储存温度 2-8°C储存
运输条件 冰袋运输
稳定性与储存 4°C 下运输。4°C 长期保存(12 个月)。收货后建议分装。
分子类型 抗体

关联靶点(人)

CD86 Tclin T淋巴细胞活化抗原CD86(T-lymphocyte activation antigen CD86) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

图片

Anti-CD86 antibody (Ab095464) - Flow Cytometry
Flow Cytometry analysis of Raji cells labelling CD86 (red) with Anti-CD86 antibody (Ab095464) at 0.1 μg/mL for 1 hour at 4°C. AffiniPure Goat anti-Mouse IgG, Fcγ fragment specific (AF647) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, mouse IgG (Ab170221). Black - Unlabelled control, cells without incubation with primary antibody.

应用

应用名称 稀释比例
Flow Cytometry

1μg/100w cells

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到3个结果

批号(Lot Number) 证书类型 货号
ZJ24F0202986 分析证书 Ab095464
ZJ23F1201931 分析证书 Ab095464
ZJ23F1201932 分析证书 Ab095464

可替换产品

引用文献

1. Vicente Rabaneda EF, Herrero-Beaumont G, Castañeda S.  (2013)  Update on the use of abatacept for the treatment of rheumatoid arthritis..  Expert Rev Clin Immunol,  (7): (599-621).  [PMID:23899231]
2. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA.  (1991)  CTLA-4 is a second receptor for the B cell activation antigen B7..  J Exp Med,  174  (3): (561-9).  [PMID:1714933]
3. Engel, P P and 8 more authors..  (1994)  The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen..  Blood,  (1): [PMID:7520767]
4. Lanier, L L LL and 7 more authors..  (1995)  CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL..  Journal of immunology (Baltimore, Md. : 1950),  (1): [PMID:7527824]
5. Jellis, C L CL and 6 more authors..  (1995)  Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86)..  Immunogenetics,  [PMID:7541777]
6. Azuma, M M and 6 more authors..  (1993)  B70 antigen is a second ligand for CTLA-4 and CD28..  Nature,  (4): [PMID:7694153]
7. Freeman, G J GJ and 7 more authors..  (1993)  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation..  Science (New York, N.Y.),  (5): [PMID:7694363]
8. Magistrelli, G G and 5 more authors..  (2001)  Identification of an alternatively spliced variant of human CD86 mRNA..  Biochemical and biophysical research communications,  (9): [PMID:11162656]
9. Schwartz, J C JC, Zhang, X X, Fedorov, A A AA, Nathenson, S G SG and Almo, S C SC..  (2001)  Structural basis for co-stimulation by the human CTLA-4/B7-2 complex..  Nature,  (29): [PMID:11279501]
10. Chen, X X, Ji, Z L ZL and Chen, Y Z YZ..  (2002)  TTD: Therapeutic Target Database..  Nucleic acids research,  (1): [PMID:11752352]
11. Goto, Eiji E and 6 more authors..  (2003)  c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity..  The Journal of biological chemistry,  (25): [PMID:12582153]
12. Zhang, Xuewu X, Schwartz, Jean-Claude D JC, Almo, Steven C SC and Nathenson, Stanley G SG..  (2003)  Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signaling..  Proceedings of the National Academy of Sciences of the United States of America,  (4): [PMID:12606712]
13. and Kremer, Joel M JM..  (2005)  Selective costimulation modulators: a novel approach for the treatment of rheumatoid arthritis..  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,  [PMID:16357751]
14. Hervey, Pauline S PS and Keam, Susan J SJ..  (2006)  Abatacept..  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,  [PMID:16573350]
15. Muzny, Donna M DM and 113 more authors..  (2006)  The DNA sequence, annotation and analysis of human chromosome 3..  Nature,  (27): [PMID:16641997]
16. Weyand, Cornelia M CM and Goronzy, Jörg J JJ..  (2006)  T-cell-targeted therapies in rheumatoid arthritis..  Nature clinical practice. Rheumatology,  [PMID:16932686]
17. and Scheinfeld, Noah N..  (2006)  Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists..  The Journal of dermatological treatment,  [PMID:16971318]
18. Vincenti, Flavio F and Luggen, Michael M..  (2007)  T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation..  Annual review of medicine,  [PMID:17020493]
19. Nogid, Anna A and Pham, David Q DQ..  (2006)  Role of abatacept in the management of rheumatoid arthritis..  Clinical therapeutics,  [PMID:17212998]
20. Reynolds, Jennifer J, Shojania, Kam K and Marra, Carlo A CA..  (2007)  Abatacept: a novel treatment for moderate-to-severe rheumatoid arthritis..  Pharmacotherapy,  [PMID:18041889]
21. and Vincenti, Flavio F..  (2008)  Costimulation blockade in autoimmunity and transplantation..  The Journal of allergy and clinical immunology,  [PMID:18269922]
22. Maxwell, Lara J LJ and Singh, Jasvinder A JA..  (2010)  Abatacept for rheumatoid arthritis: a Cochrane systematic review..  The Journal of rheumatology,  [PMID:20080922]
23. Kleinpeter, Patricia and 20 more authors..  (2019)  By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1..  Journal of virology,  (1): [PMID:30918073]

溶液计算器